StocksImmunomedics IncIMMU

IMMU

Immunomedics Inc

87.79 -0.07 (-0.08%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
87.79
B
87.96

Overview

Prev Close87.86
Day's Range87.64 - 87.73
52 Week Range8.78 - 87.73
Average Volume (3m)4.61M
1-Year Return448.25%
Beta1.5773
Market Cap20.31B
P/E Ratio
Revenue20.37M
EPS-1.7215
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.708/05/202021/07/202001/10/202030.0040.0050.0060.0070.0080.0090.00
Chart times in UTC
Industry Biotechnology
CEO Harout Semerjian, MBA
Employees 366

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2019: Immunomedics Inc's revenues increased by ∞% and amounted to 295.00K. Net income decreased by 126.51% to -357.32M. Net assets increased by 0.52% to 267.23M and EPS decreased from -1.67 to -1.84.
IMMU's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
100.00%
Net Profit Margin
-60,540.68%
Operating Margin
-1,536.66%
Return On Investment
-62.11%
06/19
09/19
12/19
03/20
Total Revenue
0
0
295K
0
Gross Profit
-1.1M
-1.06M
-764K
-1.03M
Operating Income
-67.17M
-86.77M
-91.25M
-81.97M
Net Income
-75.95M
-94.32M
-99.64M
-93.08M